New England Journal of Medicine
Updated 4 weeks ago
CDC Reports Decline of Diabetes-Related Complications
Brenda Neugent |
May 9, 2014 |
While new cases of type 2 diabetes are rising rapidly, recent research shows that complications from the disease are on the decline.
Research compiled by the Centers for Disease Control and Prevention (CDC) found that over a 20-year period, rates of the five major complications associated with diabetes - heart attack, stroke, end-stage kidney failure, lower limb amputation and deaths from hyperglycemia - all saw drastic declines.
Saxagliptin- Oral Medication Caution
Pat Piper |
Mar 30, 2014 |
The FDA wants to take another look at a pill approved in 2006 for control of glucose levels in people with type 2 diabetess. In a trial study published in the New England Journal of Medicine, saxagliptin (brand name Onglyza) was shown to coincide with an increased rate of hospitalization for heart failure of 27 percent compared to type 2s taking a placebo. The FDA has not asked prescribers and patients to stop taking saxagliptin, but to use caution while a review is underway.
Close Encounter - A Profile of a Diabetes Patient and Business Insider
Fatal error: Call to a member function getUrl() on a non-object in /home/diabetes/public_html/browse.php on line 54